Professor Solange Peters, MD, PhD, is Professor and Head of Medical Oncology - Department of Oncology UNIL CHUV.
Prof. Peters is currently in charge of teaching and patient care in the area of medical oncology and thoracic malignancies at the Department of Oncology of Lausanne University, where she is building a translational program in collaboration with the molecular oncology laboratory directed by Prof. D. Hanahan and Prof. E. Meylan in Swiss Federal Institute of Technology in Lausanne and the Ludwig Institute. Professor Solange Peters is the 2019 recipient of the Bonnie J Addario prize, the G02 Foundation having made particular mention of her supporting the advancement of women in oncology.
Prof. Peters’ main field of interest is new biomarker discovery and validation in preclinical and clinical settings. She is also strongly involved and interested in multimodality trial-building for locally advanced NSCLC as well as clinical and translational cancer immunotherapy. Her current research projects as a chair are focused on multimodality curative-intent treatment of stage III NSCLC, combined immunotherapy for the treatment of NSCLC, SCLC, thymic malignancies and mesothelioma, denosumab in advanced NSCLC, ALK, RET, EGFR as well HER2 inhibitors. She acts as the local PI of lung trials opened in Lausanne Cancer Centre, focused on phase I, predictive biomarkers and NSCLC immunotherapy. In addition, she is a co-PI of several other trials.
She is co-chair of Swiss Lung Cancer Research group, and responsible for trials organization and coordination, as well as related databases for the ETOP (European Thoracic Oncology Platform) Lungs cape project database (member of the steering committee), where she is responsible for communication, scientific coordination and member of the Foundation Council.
Dr. Peters achieved her MD from the Medical School at the University of Lausanne. Dr. Peters did her residency in Internal Medicine, followed by a Fellowship at the Multidisciplinary Oncology Centre.
Find more information about Prof. Solange Peters here:
Pr Solange Peters - Département d'oncologie - CHUV
Prof. Peters is currently in charge of teaching and patient care in the area of medical oncology and thoracic malignancies at the Department of Oncology of Lausanne University, where she is building a translational program in collaboration with the molecular oncology laboratory directed by Prof. D. Hanahan and Prof. E. Meylan in Swiss Federal Institute of Technology in Lausanne and the Ludwig Institute. Professor Solange Peters is the 2019 recipient of the Bonnie J Addario prize, the G02 Foundation having made particular mention of her supporting the advancement of women in oncology.
Prof. Peters’ main field of interest is new biomarker discovery and validation in preclinical and clinical settings. She is also strongly involved and interested in multimodality trial-building for locally advanced NSCLC as well as clinical and translational cancer immunotherapy. Her current research projects as a chair are focused on multimodality curative-intent treatment of stage III NSCLC, combined immunotherapy for the treatment of NSCLC, SCLC, thymic malignancies and mesothelioma, denosumab in advanced NSCLC, ALK, RET, EGFR as well HER2 inhibitors. She acts as the local PI of lung trials opened in Lausanne Cancer Centre, focused on phase I, predictive biomarkers and NSCLC immunotherapy. In addition, she is a co-PI of several other trials.
She is co-chair of Swiss Lung Cancer Research group, and responsible for trials organization and coordination, as well as related databases for the ETOP (European Thoracic Oncology Platform) Lungs cape project database (member of the steering committee), where she is responsible for communication, scientific coordination and member of the Foundation Council.
Dr. Peters achieved her MD from the Medical School at the University of Lausanne. Dr. Peters did her residency in Internal Medicine, followed by a Fellowship at the Multidisciplinary Oncology Centre.
Find more information about Prof. Solange Peters here:
Pr Solange Peters - Département d'oncologie - CHUV